image: medicalnewstoday

Immune markers may predict multiple sclerosis severity

September 20, 2017

Researchers uncover specific immune molecules that could act as biomarkers for more severe forms of multiple sclerosis. The findings might help to personalize treatments for those at most risk.

Multiple sclerosis (MS) is a chronic condition affecting the central nervous system, comprising the brain and spinal cord. Exactly why MS occurs is unknown, and treatment options are still limited.

Myelin is a waxy coating on nerves that is essential for the transmission of messages throughout the nervous system.

Read More on Medical News Today